TEVA logo

TEVA Accounts Payable

Latest reported$2.72B
TEVA Quarterly Accounts Payable ($0.00 → $2.72B)
High-resolution chart · PNG

TEVA accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Accounts Payable — Quarterly (USD)
Period endingAccounts Payable (USD)
2,721,000,000
2,596,031,000
2,530,961,000
2,355,000,000
2,498,000,000
2,290,000,000
2,203,000,000
2,371,000,000
2,366,000,000
2,439,000,000
2,602,000,000
2,280,000,000
2,508,000,000
2,381,000,000
1,887,000,000
1,635,000,000
1,901,000,000
1,750,000,000
1,686,000,000
1,514,000,000
1,551,000,000
1,692,000,000
1,756,000,000
1,716,000,000
1,606,000,000
1,710,000,000
1,718,000,000
1,688,000,000
1,806,000,000
1,763,000,000
1,853,000,000
1,626,000,000
1,779,000,000
1,929,000,000
2,069,000,000
2,370,000,000
2,278,000,000
2,378,000,000
2,157,000,000
4,953,000,000
3,855,000,000
3,528,000,000
1,918,000,000
2,964,000,000
2,976,000,000
3,036,000,000
3,171,000,000
2,894,000,000
3,026,000,000
3,143,000,000
3,317,000,000
3,049,000,000
0
0
0
0
0
0
6,213,000,000
0
0
0
5,476,000,000
0
0
0
5,019,000,000
2,189,000,000
2,129,000,000
2,060,000,000
4,653,000,000
1,590,000,000
1,505,000,000
1,361,000,000
1,383,000,000
3,266,000,000
3,213,000,000
3,120,000,000
2,557,000,000
3,207,000,000
2,937,900,000
2,619,700,000
1,885,000,000
1,776,100,000
1,669,800,000
1,684,600,000
1,644,000,000
1,521,900,000
1,394,700,000
1,344,300,000
1,050,700,000
956,200,000
941,600,000
849,600,000
785,700,000
709,900,000
670,100,000
558,900,000
531,598,000
524,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.